Solving MS

To fund scientific and/or medical research and to advocate for people with Multiple Sclerosis (MS). #SolvingMS

[Rich Welsh @rwelsh63]

One step closer to a real treatment!

[NervGen @NervgenP]

It was wonderful bringing together investigators and site staff for RESTORE, our Phase 3 study evaluating NVG-291 in chronic cervical spinal cord injury.

Thank you for the work that begins long before a participant's first visit and continues throughout the study.

#SCI #RESTORE

[Solving MS @SolvingMS]

@NARCOMS1993 has been a leading repository of MS patient data for years, which helps power research to overcome the disease.
Everyone with MS needs to fill out their survey!

[NARCOMS @NARCOMS1993]

Do you have Multiple Sclerosis and mobility issues? Want to help with research?

Enroll in the NARCOMS Registry today!
https://t.co/rjApd1lY2x

[NARCOMS @NARCOMS1993]

Big Takeaways from RealTalk MS Episode 423 with Dr. Robert Fox! 🎙️

Dr. Fox, breaks down what research shows about infections like COVID-19 and how they affect symptom severity in people with MS.

[Solving MS @SolvingMS]

@RealTalkMS_jon @helen_tremlett @UBC @ubcneuro Jon thanks for doing these great interviews that gets important info out to PwMS!

[Jon Strum @RealTalkMS_jon]

https://t.co/kfDsxMiPU9 MS begins long before the first neurologic symptom.
Dr. Helen Tremlett explains the MS prodrome — subtle changes that may appear years before diagnosis — and why this research matters for patient care on RealTalk MS.
@helen_tremlett @UBC @ubcneuro @MSCanOfficial
#MultipleSclerosis #MSResearch #ACTRIMS #ACTRIMSForum #ACTRIMS2026

[Solving MS @SolvingMS]

@Brandon_Beaber Disappointing we lose another phase 3 MS drug.
But THANK YOU for calling out Sanofi's questionable data tactics!

Any hope for other phase 3 for MS: Fenebrutinib, Remibrutinib, Mastinib, Frexalimab, Vidofludimus_Calcium?

[Dr. Brandon Beaber @Brandon_Beaber]

2024 updated multiple sclerosis diagnostic criteria in visual form. https://t.co/bnWqHR15o5

[Solving MS @SolvingMS]

@BrainInflCollab Mara Kuvaldina's team at Columbia-Lyme already has 2 #lyme trials running using:
• Transcranial Direct Current Stimulation (tDCS)
and
• Vagus Nerve Stimulation
https://t.co/v7A5Hlafxe

[Solving MS @SolvingMS]

Treat Brain Fog with rTMS & Vagus Nerve Stimulation (VNS) electrical stimulation.

A great great alternative to drugs!
Free webinar from @BrainInflCollab Jan 22 3PM ET

[Brain Inflammation Collaborative @BrainInflCollab]

🧠 Join us Jan 22 @ 3pm ET for Untangling Brain Fog with Mara Kuvaldina, PhD (Columbia). Learn how neuroinflammation shapes cognition & what new neuromodulation research means for chronic illness. 🔬✨ Sign up for free: https://t.co/qPkGyEks77

[Solving MS @SolvingMS]

@BrainInflCollab @BrainInflCollab Thank you for this Brain Fog webinar!

Treating with rTMS & Vagus Nerve Stimulation (VNS) electrical stimulation is a great alternative to drugs!

This is a major problem for Multiple Sclerosis, and rTMS helps https://t.co/nbQQUucUwK

[Solving MS @SolvingMS]

@mercola No sugar!

[Aaron Boster MD @AaronBosterMD]

Vidofludimus Calcium for MS https://t.co/XDVAqwMgcU via @Brandon_Beaber

[Shift.ms @shiftms]

🚨 New video series alert🚨

We've teamed up with @AaronBosterMD to create 'Power of Persuasion', a brand new video series all about self-advocacy. Empowering yourself to speak up for yourself to your MS team can feel scary.

1/2

[Solving MS @SolvingMS]

@US_FDA @DrMakaryFDA Our database tracks regenerative medicine clinical trials. MS Cures & Repair. Ready to accelerate!
12 for #StemCells
20 for #Remyelination
8 for #RepurposedDrugs #Antivirals #EBVcausesMS
76 total
https://t.co/ReabjdqEuX

[Solving MS @SolvingMS]

Great tips on how to get better care from your MS team!

[Shift.ms @shiftms]

🚨 New video series alert🚨

We've teamed up with @AaronBosterMD to create 'Power of Persuasion', a brand new video series all about self-advocacy. Empowering yourself to speak up for yourself to your MS team can feel scary.

1/2

[Solving MS @SolvingMS]

If you have MS please make comments to @US_FDA
We need accelerated approval of regenerative and curative therapies!

[Solving MS @SolvingMS]

@US_FDA @DrMakaryFDA @SolvingMS Our database tracks regenerative medicine clinical trials. Cures & Repair. Ready to accelerate!
12 for #StemCells
20 for #Remyelination
8 for #RepurposedDrugs #Antivirals #EBVcausesMS
76 total
https://t.co/ReabjdqEuX

[Solving MS @SolvingMS]

80% of MS patients have spinal cord injury from scarring and cord atrophy. We are thrilled to see the results of @NervgenP SCI repair after only 12 weeks!

[NervGen @NervgenP]

“We achieved our primary endpoint demonstrating improved hand-motor connectivity and showed positive improvement in hand function in the chronic cohort of our Phase 1b/2a trial,” said Mike Kelly, NervGen’s President and Chief Executive Officer.

Chief Medical Officer, Dr. Daniel Mikol, will present the positive study results in-person today at the @ASIA_spine 2025 Annual Scientific Meeting.

Learn more: https://t.co/QbgucvSFw6

#SCI #clinicaltrial #ASIA2025 #ASIA2025SCIAnnualMeeting

[Solving MS @SolvingMS]

In 2025, three antiviral phase 3 trials for EBV in MS are launching!
#EBVcausesMS

https://t.co/5r1zJhXWDQ

[Solving MS @SolvingMS]

@US_FDA @DrMakaryFDA @SolvingMS Our database tracks regenerative medicine clinical trials. Cures & Repair. Ready to accelerate!
12 for #StemCells
20 for #Remyelination
8 for #RepurposedDrugs #Antivirals #EBVcausesMS
76 total
https://t.co/ReabjdqEuX